Ligand Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO

Todd Christopher Davis

CEOTodd Christopher Davis

Employees

Employees68

Headquarters

Jupiter, Florida

HeadquartersJupiter, Florida

Founded

1987

Founded1987

Employees

Employees68

LGND Key Statistics

Market cap

3.32B

Market cap3.32B

Price-Earnings ratio

-41.39

Price-Earnings ratio-41.39

Dividend yield

—

Dividend yield—

Average volume

240.04K

Average volume240.04K

High today

$170.78

High today$170.78

Low today

$165.13

Low today$165.13

Open price

$165.53

Open price$165.53

Volume

172.56K

Volume172.56K

52 Week high

$170.78

52 Week high$170.78

52 Week low

$93.58

52 Week low$93.58

LGND News

TipRanks 2d

Ligand Pharma Amends Credit Agreement for Stability

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.